3i, LP 13D and 13G filings for Processa Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-23 5:54 pm Purchase |
2025-06-17 | 13G | Processa Pharmaceuticals, Inc. PCSA |
3i, LP | 1,681,944 4.900% |
1,681,944 (New Position) |
Filing |